Augustin M., Glaeske G., Radtke M. A., Christophers E., Reich K., Schäfer I. Epide-miology and comorbidity of psoriasis in children. British Journal of Dermatology. 2010; 162:(3)633-636

Benoit S., Hamm H. Childhood psoriasis. Clinics in dermatology. 2007; 25:(6)555-562

Bronckers IMGJ, Paller AS, van Geel MJ, van de Kerkhof PCM, Seyger MMB Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Paediatric Drugs. 2015; 17:(5)373-384

Dawn A., Yosipovitch G. Treating itch in psoriasis. Dermatology nursing. 2006; 18:(3)

de Jager M. E., De Jong E. M., Evers A. W., Van De KERKHOF P. C., SEYGER M. M. The burden of childhood psoriasis. Pediatric dermatology. 2011; 28:(6)736-737

de Moll EH, Chang MW, Strober B Psoriasis in adults and children: Kids are not just little people. Clinics in Dermatology. 2016; 34:(6)717-723

Dogra S., Kaur I. Childhood psoriasis. Indian Journal of Dermatology, Venereology, and Leprology. 2010; 76:(4)

Evers A. W., Spillekom-van K. S., Beugen S. V. Psychological treatments for derma-tological conditions. 2016;

Gonzalez J, Cunningham K, Perlmutter J, Gottlieb A Systematic Review of Health-Related Quality of Life in Adolescents with Psoriasis. Dermatology (Basel, Switzerland). 2016; 232:(5)541-549

Joachim G., Acorn S. Stigma of visible and invisible chronic conditions. Journal of ad-vanced nursing. 2000; 32:(1)243-248

Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y The psychosocial burden of psori-asis. Am J Clin Dermatol. 2005; 6:383-92

Lewis-Jones MS, Finlay AY The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995; 132:942-9

Lawton S. Psoriasis presentations and potential treatment pathways. Practice Nursing. 2018; 29:(11)517-520

Magin P, Adams J, Heading G, Pond D, Smith W. Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: Results of a qualitative study. Scand J Caring Sci. 2008; 22:(3)430-6

Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001; 18:(3)188-98

National Institute for Health and Care Excellence. Psoriasis: assessment and man-agement. Clinical guideline 153. (accessed on 21 October 2019)

National Institute for Health and Care Excellence. The British National formulary. DITHRANOL. 2019. (Accessed on: 21/10/2019)

Olson AL, Seidler AB, Goodman D, Gaelic S, Nordgren R. School professionals' perceptions about the impact of chronic illness in the classroom. Arch Pediatr Adolesc Med. 2004; 158:(1)53-8

BNF for Children [78, 2019].: BMJ Group, Pharmaceutical Press, and RCPCH Publications; 2019

Primary Care Dermatology Society. 2019. (accessed on 21 October 2019)

Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000; 17:(3)174-8

Renton C. The effects of psoriasis on children's health and wellbeing. British Journal of School Nursing. 2013; 8:(2)

Rogers M. Childhood psoriasis. Current Opinion in Pediatrics. 2002; 14:(4)404-409

Salman A, Yucelten AD, Sarac E, Saricam MH, Perdahli-Fis N. Impact of psoriasis in the quality of life of children, adolescents and their families: A cross-sectional study. An Bras Dermatol. 2018; 93:(6)819-823

Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol. 2000; 142:(5)899-907

Schmid-Ott G, Malewski P, Kreiselmaier I [Psychosocial consequences of psoriasis – an empirical study of disease burden in 3753 affected people]. Hautarzt. 2005; 56:(5)466-72

Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol. 1992; 128:(1)39-42

Todberg T, Egeberg A, Jensen P, Gislason G, Skov L. Psychiatric comorbidities in children and adolescents with psoriasis: a population-based cohort study. The British Journal of Dermatology. 2017; 177:(2)551-553

The Psoriasis and Psoriatic Arthritis Association. (accessed on 21 October 2019)

Tucker R. Assessment and management of psoriasis in adults in primary care. Clinical Pharma-cist. 2018; 10:(3)

Van Onselen J. Managing psoriasis in children and young people. Nurse Prescribing. 2013; 11:(7)

Psoriasis: Management and self-care

02 March 2020
Volume 1 · Issue 1


Psoriasis is a common skin condition that affects an estimated 3% of the population. In one third of cases, psoriasis will develop during childhood or adolescence. Juvenile psoriasis is also associated with other co-morbidities such as hyperlipidaemia, obesity, hypertension, diabetes mellitus, rheumatoid arthritis and Crohn's disease. Understanding this illness means that health-care professionals such as school nurses can help by providing schools with appropriate information about the condition, improving its management and providing education to help reduce stigma.

Psoriasis is a common skin condition which affects an estimated 3% of the population. Commonly considered as an adult condition approximately one third of people develop the disease in childhood (Bronckers et al, 2015; Gonzalez et al, 2016; The Psoriasis and Psoriatic Arthritis Association, 2019; Primary Care Dermatology Society, 2019). Certainly, Benoit and Hamm (2007) suggest that in one third of cases, psoriasis starts in the first or second decade of life. Juvenile psoriasis is also associated with other comorbidities such as hyperlipidaemia, obesity, hypertension, diabetes mellitus, rheumatoid arthritis and Crohn's disease (Augustin et al, 2010). Understanding this illness means that health-care professionals, such as school nurses can help by providing educators with appropriate information about it, educate those in the classroom and help reduce stigma for any children or young people with the condition (Olson et al, 2004).

Register now to continue reading

Thank you for visiting Journal of Child Health and reading some of our peer-reviewed resources for children’s health professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month